37.77
Harrow Inc stock is traded at $37.77, with a volume of 496.79K.
It is up +0.56% in the last 24 hours and down -21.61% over the past month.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
See More
Previous Close:
$37.56
Open:
$37.68
24h Volume:
496.79K
Relative Volume:
0.71
Market Cap:
$1.40B
Revenue:
$154.15M
Net Income/Loss:
$-33.58M
P/E Ratio:
-39.34
EPS:
-0.96
Net Cash Flow:
$-20.74M
1W Performance:
-1.95%
1M Performance:
-21.61%
6M Performance:
+52.48%
1Y Performance:
-16.18%
Harrow Inc Stock (HROW) Company Profile
Name
Harrow Inc
Sector
Phone
615.733.4731
Address
1A BURTON HILLS BLVD, NASHVILLE, CA
Compare HROW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HROW
Harrow Inc
|
37.77 | 1.39B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-12-25 | Initiated | BTIG Research | Buy |
| Jun-10-25 | Initiated | William Blair | Outperform |
| Feb-06-25 | Initiated | H.C. Wainwright | Buy |
| Dec-04-24 | Reiterated | B. Riley Securities | Buy |
| Apr-11-24 | Initiated | Craig Hallum | Buy |
| Sep-08-22 | Resumed | B. Riley Securities | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Sep-24-21 | Initiated | Aegis Capital | Buy |
| Jul-02-21 | Initiated | Ladenburg Thalmann | Buy |
View All
Harrow Inc Stock (HROW) Latest News
Westside Investment Management Inc. Raises Stake in Harrow, Inc. $HROW - MarketBeat
Key resistance and support levels for Harrow Inc.July 2025 Snapshot & Daily Risk Controlled Trade Plans - newser.com
Can Harrow Inc. stock sustain market leadershipTrade Signal Summary & Technical Pattern Alert System - newser.com
How Harrow Inc. stock reacts to global recession fearsRate Cut & Verified Momentum Watchlists - newser.com
What is the fair value of Harrow Inc. stock nowJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Should you hold or exit Harrow Inc. nowJuly 2025 Big Picture & Weekly Market Pulse Updates - newser.com
What insider trading reveals about Harrow Inc. stockProfit Target & Step-by-Step Trade Execution Guides - newser.com
Harrow, Inc. (HROW) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Best data tools to analyze Harrow Inc. stock2025 Investor Takeaways & Expert Approved Trade Ideas - newser.com
Custom watchlist performance reports with Harrow Inc.Weekly Earnings Recap & Community Verified Trade Signals - newser.com
Why Harrow Inc. stock is in analyst buy zone2025 Winners & Losers & Risk Managed Investment Strategies - newser.com
What risks investors should watch in Harrow Inc. stockWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com
Will Harrow Inc. stock pay special dividends2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com
Corrado Advisors LLC Purchases Shares of 7,366 Harrow, Inc. $HROW - MarketBeat
Analyzing Harrow Inc. with risk reward ratio chartsPortfolio Profit Report & Trade Opportunity Analysis - newser.com
D.A. Davidson & CO. Sells 13,255 Shares of Harrow, Inc. $HROW - MarketBeat
Harrow, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo
Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025 - The Manila Times
Harrow (NASDAQ: HROW) sets third-quarter results Nov 10; call and webcast Nov 11 - Stock Titan
Kornitzer Capital Management Inc. KS Acquires New Position in Harrow, Inc. $HROW - MarketBeat
Harrow Inc Stock (HROW) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):